Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?
Crossref DOI link: https://doi.org/10.1007/s12185-016-2164-2
Published Online: 2016-12-19
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Atilla, Erden
Atilla, Pinar Ataca
Demirer, Taner
License valid from 2016-12-19